2-222294110-T-C

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS1

The ENST00000409828.7(PAX3):​c.643A>G​(p.Ser215Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,611,416 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 1 hom. )

Consequence

PAX3
ENST00000409828.7 missense

Scores

1
1
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.178

Publications

0 publications found
Variant links:
Genes affected
PAX3 (HGNC:8617): (paired box 3) This gene is a member of the paired box (PAX) family of transcription factors. Members of the PAX family typically contain a paired box domain and a paired-type homeodomain. These genes play critical roles during fetal development. Mutations in paired box gene 3 are associated with Waardenburg syndrome, craniofacial-deafness-hand syndrome, and alveolar rhabdomyosarcoma. The translocation t(2;13)(q35;q14), which represents a fusion between PAX3 and the forkhead gene, is a frequent finding in alveolar rhabdomyosarcoma. Alternative splicing results in transcripts encoding isoforms with different C-termini. [provided by RefSeq, Jul 2008]
PAX3 Gene-Disease associations (from GenCC):
  • craniofacial-deafness-hand syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Waardenburg syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Waardenburg syndrome type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Waardenburg syndrome type 3
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 47 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Gene score misZ: 1.618 (below the threshold of 3.09). Trascript score misZ: 1.2909 (below the threshold of 3.09). GenCC associations: The gene is linked to Waardenburg syndrome type 3, Waardenburg syndrome type 1, Waardenburg syndrome, craniofacial-deafness-hand syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.004402578).
BP6
Variant 2-222294110-T-C is Benign according to our data. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-222294110-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 227833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0016 (244/152364) while in subpopulation AFR AF = 0.00551 (229/41584). AF 95% confidence interval is 0.00492. There are 0 homozygotes in GnomAd4. There are 112 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX3NM_181458.4 linkc.586+57A>G intron_variant Intron 4 of 8 ENST00000392070.7 NP_852123.1 P23760-7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX3ENST00000392070.7 linkc.586+57A>G intron_variant Intron 4 of 8 1 NM_181458.4 ENSP00000375922.3 P23760-7

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
243
AN:
152246
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00550
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000409
AC:
102
AN:
249652
AF XY:
0.000341
show subpopulations
Gnomad AFR exome
AF:
0.00542
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000168
AC:
245
AN:
1459052
Hom.:
1
Cov.:
36
AF XY:
0.000161
AC XY:
117
AN XY:
725436
show subpopulations
African (AFR)
AF:
0.00583
AC:
195
AN:
33422
American (AMR)
AF:
0.000314
AC:
14
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25922
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39652
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85982
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53172
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5752
European-Non Finnish (NFE)
AF:
0.00000631
AC:
7
AN:
1110186
Other (OTH)
AF:
0.000365
AC:
22
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152364
Hom.:
0
Cov.:
32
AF XY:
0.00150
AC XY:
112
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00551
AC:
229
AN:
41584
American (AMR)
AF:
0.000784
AC:
12
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000679
Hom.:
1
Bravo
AF:
0.00189
ESP6500AA
AF:
0.00377
AC:
10
ESP6500EA
AF:
0.000217
AC:
1
ExAC
AF:
0.000478
AC:
58
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 07, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 23, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser215Gly in exon 4A of PAX3: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (56/10348) of African chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs202175449). In addition, this amino acid position is not conserved acros s species with most other species (including mammals) having a glycine (Gly) at amino acid position 215. -

PAX3-related disorder Benign:1
Aug 15, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
6.9
DANN
Benign
0.46
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.17
T
M_CAP
Benign
0.069
D
MetaRNN
Benign
0.0044
T
MetaSVM
Uncertain
0.68
D
PhyloP100
0.18
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.22
Sift
Pathogenic
0.0
D
Polyphen
0.0
B
Vest4
0.14
MVP
0.24
ClinPred
0.021
T
GERP RS
0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202175449; hg19: chr2-223158829; API